Levocarb

Carbidopa/Levodopa, the active ingredient in Levocarb, is a DOPA decarboxylase inhibitor and dopamine precursor presented as an oral tablet for oral use. It is employed to manage the motor symptoms of Parkinson's disease in adult patients.

GNH USA supplies Levocarb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export. Clients benefit from reliable delivery timelines, temperature‑controlled logistics where required, and dedicated technical support throughout the procurement process.

Levocarb (carbidopa/levodopa) is used in the management of Parkinsonian disorders by restoring central dopamine levels. - Parkinson's disease: improves motor function, reducing bradykinesia, rigidity, and tremor. - Parkinsonian syndrome secondary to drug toxicity: alleviates symptoms when dopamine deficiency is present. - Levodopa‑responsive movement disorders: provides symptomatic relief for conditions such as early‑stage Parkinsonism.

Levocarb may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Dizziness or light‑headedness - Orthostatic hypotension - Headache - Insomnia - Dry mouth

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Psychiatric disturbances such as hallucinations or confusion - Severe hypotension or arrhythmias - Neuroleptic malignant syndrome - Allergic reactions including skin rash or angioedema - Respiratory depression (very rare)

When prescribing Levocarb, clinicians should consider several safety measures. - Dose titration: start with a low dose and increase gradually under medical supervision. - Renal impairment: adjust dose as needed based on renal function. - Cardiovascular disease: monitor blood pressure regularly for orthostatic changes. - Psychiatric history: assess risk of hallucinations or confusion, especially in older adults. - Store at room temperature: keep in the original container, protect from moisture and light.

Levocarb can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may cause hypertensive crisis. - Anticholinergic agents: can exacerbate confusion or cognitive impairment. - Antipsychotics such as haloperidol: reduce levodopa efficacy and may worsen Parkinsonian symptoms.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: may increase risk of serotonin syndrome. - Iron or calcium supplements: decrease levodopa absorption; separate dosing by at least 2 hours. - High‑protein meals: may reduce levodopa bioavailability; advise timing of drug relative to meals.